Future LRMN Events

LRMN & Cell Therapy Catapult

The September 2014 meeting of the London Regenerative Medicine Network will be focused on the topic of clinical applications of cell therapy, and three experts with differing experiences from industrial and hospital settings will be presenting their experience in the clinical evaluation of cell therapies.

This meeting is the second meeting supported by the Cell Therapy Catapult and is FREE OF CHARGE to attend. The Cell Therapy Catapult is a centre of excellence in the translation of cell therapies from "bench to bedside". Its vision is for the UK to be a global leader in the development, delivery and commercialisation of cell therapy, making it a location for business start-up and growth. Based in London at Guy's Hospital, the centre plans to work in collaboration with others to take products through early clinical trials, providing business, clinical, technical, manufacturing and regulatory expertise and to facilitate access to the NHS.

The meeting will take place on Wednesday 24th September 2014 at 6.00pm in the Wilkins Gustave Tuck Lecture Theatre, Wilkins Building, University College London - a short walk from Euston Square, Goodge Street and Warren Street Tube Stations and Euston Station.

Registration: 6.00 - 6.30pm
Presentations: 6.30 - 8.25pm
Networking Reception 8.25 - 10.00pm



18.00 - Registration and networking over tea and coffee in the Gustave Tuck Lecture Theatre (Wilkins Building, UCL), while previewing the LRMN Cell Therapy Masterclass with Dr. Mark Lowdell, Director of Cellular Therapeutics Laboratory, Royal Free Hospital (London, UK)

18.30 - Welcome - Dr. Natalie Mount (Cell Therapy Catapult) and Dr. Emily Culme-Seymour (LRMN)

18.35 - Standing on the shoulders of giants: Shaping the future of cell therapies by reflecting on their past - Dr. Sven Kili, Genzyme Biosurgery (Oxford, UK)

19.05 - Q & A

19.10 - Are tissue engineered organs disruptive technology? - Prof. Martin Birchall, UCL Ear Institute (London, UK)

19.40 - Q & A

19.45 - Human embryonic stem cell-derived cardiac progenitors for cardiac repair: A translational experience - Prof. Philippe Menasché, Hôpital Européen Georges Pompidou (Paris, France)

20.15 - Q & A

20.20 - Closing remarks - Dr. Natalie Mount (Cell Therapy Catapult) and Dr. Emily Culme-Seymour (LRMN)

20.25 - 22.00 - LRMN Reception - Network whilst enjoying a glass of wine or two in G08, Dept. of Civil, Environmental & Geomatic Engineering (Chadwick Building, UCL)



Cell Therapy Catapult

Regenerative Medicine'


PLEASE NOTE THAT DUE TO LECTURE THEATRE SEATING CAPACITY, IF YOU WISH TO ATTEND THIS EVENT YOU MUST REGISTER, OTHERWISE UNFORTUNATELY YOU WILL NOT BE ABLE TO GAIN ADMISSION. Seat allocation is on a first come, first served basis. If you wish to attend, all that is required is to email office@lrmn.com and type 'I will attend' in the subject box. Please only register if you can definitely make the meeting.

The LRMN Team very much look forward to welcoming you at 6.00pm on Wednesday 24th September 2014 for an event that will focus on the very latest in clinical applications of cell therapy.


LRMN & Miltenyi

The LRMN is also working together again with Miltenyi Biotec to hold another event.

Miltenyi provide products and services that advance biomedical research and cellular therapy. Regarding stem cell research, currently Mitenyi’s emphasis is on developing tools for the isolation, analysis, and culture of embryonic stem cells, induced pluripotent stem cells, tissue (e.g. neural, cardiac and hepatic) stem cells and cancer stem cells. The latest company developments focus on re-programming, directed differentiation and enrichment of the resulting differentiated cells.

More information on
this event, including a finalised date and the programme will be given in due course, with invitations sent out to the LRMN mailing list as usual.